01. Doctor Overview
Dr. Seth D. Force completed his medical degree at Tulane University School of Medicine before completing his residency, followed by a thoracic surgery fellowship at the Washington University School of Medicine. He is board certified in general and thoracic surgery and focuses his clinical practice on thoracic oncology, reflux surgery, minimally invasive thoracic surgery, lung transplantation and micro-invasive treatment of hyperhydrosis.
Dr. Force has been a faculty member at the Emory University School of Medicine since 2003, where he currently holds several professorships. As Surgical Director of Emory’s Adult Lung Transplant Program, he has improved survival rates and increased the program’s lung transplant volume from 10 to 30 per year.
02. Fast Facts
Doctor Fast Facts
Main Specialty: Thoracic Surgery
Other Interests & Specialties: Thoracic oncology, reflux surgery, minimally invasive thoracic surgery, lung transplantation, microinvasive hyperhidrosis and researching the outcomes of lung transplantation and thoracic disease.
Certifications, Awards & Accolades: American Board of Radiology Certification in Radiation Oncology, Emory Provider Excellence Award, Atlanta’s Top Doctors Award, America’s Top Surgeons Award from the Consumers’ Research Council of America, Thoracic Surgery Teacher of the Year Award from Emory University School of Medicine
Education & Experience:
- Residency for General Surgery at University of Pennsylvania Health System
- Fellowship for Thoracic Surgery at Washington University
- Medical Degree and additional training at Tulane University School of Medicine
Video-Assisted Thoracoscopic Surgery Segmentectomy: A Safe and Effective Procedure. The Annals of Thoracic Surgery. May 2010;89(5):1571-1576. doi: 10.1016/j.athoracsur.2010.01.061
Efficacy of Oral Ribavirin in Lung Transplant Patients With Respiratory Syncytial Virus Lower Respiratory Tract Infection. The Journal of Heart and Lung Transplantation. January 2009;28(1):67-71. doi: 10.1016/j.healun.2008.10.008
Cationic lipid: bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor models. Cancer Research. June 2000;60(11).